GLK-401

N/A

Report date: 2025/04/21 15:08:58
NME

Base Information

Drug NameGLK-401
Drug Alias NameIVT Multi-Kinase InhibitorGLK-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphotransferases inhibitors
TargetsPhosphotransferases
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaukos Corp
China Registration ClassN/A

Develop Information

Active CompaniesGlaukos Corp
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A